Be Biopharma is developing B ceaBe Biopharma is a biotech research company that develops a class of B cells as medicines.lls as medicines.
Be Biopharma is a biotech research company that develops a class of B cells as medicines.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Apr 14, 2022 | Series B | $130M | 1 |
ARCH Venture Partners
|
— | Detail |
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
ARCH Venture Partners
|
Yes | Series B |